Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.
作者信息
Kocoglu Mehmet H, Richardson Paul G, Mo Clifton C, Rapoport Aaron P, Atanackovic Djordje
机构信息
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
Dana Farber Cancer Institute, Boston, MA.
出版信息
Haematologica. 2024 Jul 1;109(7):2372-2377. doi: 10.3324/haematol.2023.284793.
Abstract
摘要
Zotero 插件